Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ofloxacin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1030911A details a novel one-pot method for quinolone carboxylic acid, offering significant cost reduction and streamlined manufacturing for pharmaceutical intermediates.
Novel catalytic route for ciprofloxacin intermediate. High yield, low cost, scalable manufacturing process for pharmaceutical intermediates.
Patent CN105732660B reveals a low-toxicity hydrolysis method for levofloxacin intermediate, ensuring high purity and supply chain stability for pharmaceutical manufacturers.
Novel process using tri-n-propylamine improves yield and safety for ciprofloxacin intermediates. Cost-effective and scalable manufacturing solution.
Patent CN1305849C reveals a cost-effective 3-step synthesis for 3-methylaminopiperidine, eliminating noble metal catalysts and significantly improving yield for pharmaceutical manufacturing.
Patent CN100432060C details advanced synthesis of levofloxacin intermediates. Enhance supply chain reliability and reduce manufacturing costs with optimized chiral resolution.
Novel condensation route for Ofloxacin offering high yield and purity. Reduces steps and waste for cost-effective API manufacturing.
Patent CN103113290A details a cost-effective Pd/C catalyzed route for 3-methylaminopiperidine, offering significant supply chain advantages for fluoroquinolone producers.